Newborn affected by other maternal noxious substances
ICD-10 P04.8 is a billable code used to indicate a diagnosis of newborn affected by other maternal noxious substances.
P04.8 refers to newborns who are affected by maternal exposure to noxious substances, which can include drugs, alcohol, and tobacco that are transmitted through the placenta or breast milk. Maternal drug use, such as opioids, stimulants, or sedatives, can lead to withdrawal symptoms in the newborn, known as Neonatal Abstinence Syndrome (NAS). Alcohol exposure can result in Fetal Alcohol Spectrum Disorders (FASD), leading to a range of physical, behavioral, and learning problems. Tobacco use during pregnancy is associated with low birth weight, preterm birth, and respiratory issues in newborns. The clinical management of these infants often requires a multidisciplinary approach, including neonatology, pediatrics, and social services, to address both immediate health concerns and long-term developmental needs. Accurate coding is essential for appropriate treatment planning and resource allocation.
Detailed maternal history, including substance use, prenatal care, and delivery complications.
Newborns presenting with withdrawal symptoms, low birth weight, or developmental delays.
Consider the need for a multidisciplinary approach and potential long-term follow-up for developmental assessments.
Comprehensive developmental assessments and ongoing monitoring of growth and behavior.
Pediatric visits for developmental delays or behavioral issues stemming from prenatal substance exposure.
Documentation should reflect the impact of maternal substance use on the child's health and development.
Used for newborns affected by maternal noxious substances requiring initial evaluation.
Document maternal history and any immediate interventions required.
Neonatologists should ensure comprehensive assessments are performed.
Coders must ensure that the maternal history of substance use is clearly documented, including the type of substance, timing of exposure, and any related neonatal symptoms. This information is crucial for accurate coding and appropriate care planning.
